Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Minocycline-containing dual versus bismuth quadruple therapy for Helicobacter pylori eradication
ChiCTR2400089850Phase 4Recruiting
- Sponsor
- West China Hospital of Sichuan University
- Start
- Aug 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of minocycline, amoxicillin and bismuth subsalicylate in Helicobacter pylori infection (4 arms), sponsored by West China Hospital of Sichuan University. Primary endpoint: Helicobacter pylori eradication rate. Started Aug 2024; status: recruiting.
02
Drugs
minocyclineamoxicillinbismuth subsalicylate
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on ChiCTR2400089850.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400089850.